Page last updated: 2024-09-03

imatinib mesylate and Dengue

imatinib mesylate has been researched along with Dengue in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bekerman, E; Einav, S	1
Chamnanchanunt, S; Iam-arunthai, K; Nakhakes, C; Suwanban, T; Thungthong, P	1

Other Studies

2 other study(ies) available for imatinib mesylate and Dengue

Article	Year
Infectious disease. Combating emerging viral threats. Science (New York, N.Y.), 2015, Apr-17, Volume: 348, Issue:6232 Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses	2015
Dengue virus infection in a patient with chronic myeloid leukemia. The Southeast Asian journal of tropical medicine and public health, 2012, Volume: 43, Issue:4 Topics: Adult; Antineoplastic Agents; Benzamides; Dengue; Hemorrhage; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines	2012

Article

Year

Infectious disease. Combating emerging viral threats.

Science (New York, N.Y.), 2015, Apr-17, Volume: 348, Issue:6232

Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses

2015

Dengue virus infection in a patient with chronic myeloid leukemia.

The Southeast Asian journal of tropical medicine and public health, 2012, Volume: 43, Issue:4

Topics: Adult; Antineoplastic Agents; Benzamides; Dengue; Hemorrhage; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines

2012